Immunity Enhancement in Immunocompromised Gastrointestinal Cancer Patients with Allogeneic Umbilical Cord Blood Mononuclear Cell Transfusion

Table 1

Patients’ characteristics.

Characteristics	UCMCs transfusion	No-transfusion	value
Number of patients	63	67
Age (years), mean (range)	55.4 (23–80)	56.3 (27–77)	>0.05
Sex			>0.05
Female	21 (33.3%)	27 (40.3%)
Male	42 (66.6%)	40 (59.7%)
Diseases			>0.05
Gastric lymphoma	2 (3.2%)	2 (3.0%)
Gastric adenocarcinoma	29 (46.0%)	29 (43.3%)
Colon adenocarcinoma	24 (38.1%)	26 (38.8%)
Rectal carcinoma	7 (11.1%)	10 (14.9%)
Langerhans cell sarcoma in small intestine	1 (1.6%)	0 (0%)
History of previous treatments			>0.05
Chemotherapy only	19 (30.2%)	22 (32.8%)
Radio- & chemotherapy	9 (14.3%)	11 (16.4%)
Surgery & chemotherapy	34 (54.0%)	32 (47.8%)
Surgery & radiotherapy	1 (1.6%)	2 (3.0%)

No statistical test is provided due to small sample size.